Published in J Nucl Med on August 01, 1996
Lipid-based nanotherapeutics for siRNA delivery. J Intern Med (2010) 2.15
Alendronate-coated long-circulating liposomes containing 99mtechnetium-ceftizoxime used to identify osteomyelitis. Int J Nanomedicine (2015) 0.87
Therapeutic efficacy of liposome-encapsulated gentamicin in rat Klebsiella pneumoniae pneumonia in relation to impaired host defense and low bacterial susceptibility to gentamicin. Antimicrob Agents Chemother (2001) 0.83
Nanoparticle approaches against bacterial infections. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2014) 0.83
Imaging experimental intraabdominal abscesses with 99mTc-PEG liposomes and 99mTc-HYNIC IgG. Ann Surg (1999) 0.81
Technetium-99m labelled liposomes to image experimental arthritis. Ann Rheum Dis (1997) 0.80
Illuminating the physiology of extracellular vesicles. Stem Cell Res Ther (2016) 0.78
Polymer therapeutics in surgery: the next frontier. J Interdiscip Nanomed (2016) 0.75
Nuclear molecular imaging with nanoparticles: radiochemistry, applications and translation. Br J Radiol (2015) 0.75
Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial. Lancet (2001) 6.82
The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med (1989) 5.02
Dimensional assessment of chronic fatigue syndrome. J Psychosom Res (1994) 4.35
Hereditary periodic fever. N Engl J Med (2001) 4.05
Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev (2000) 3.69
Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group. Nat Genet (1999) 3.44
Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis (1990) 3.20
Adverse reactions to co-trimoxazole in HIV infection. Lancet (1991) 3.16
Mycobacterium tuberculosis Beijing genotype strains associated with febrile response to treatment. Emerg Infect Dis (2001) 2.35
Between the Scylla and Charybdis of peptide radionuclide therapy: hitting the tumor and saving the kidney. Eur J Nucl Med (2001) 2.32
The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects. Arch Neurol (1996) 2.09
[Measurement of the body temperature of adults by rectal digital thermometer and the infrared tympanic thermometer: equally good results in the department of internal medicine]. Ned Tijdschr Geneeskd (1997) 2.04
Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections. J Clin Invest (1996) 2.03
[Chronic fatigue syndrome. I. Somatological hypothesis]. Ned Tijdschr Geneeskd (1991) 2.01
[Optimization of the antibiotics policy in the Netherlands. II. SWAB guidelines for the antimicrobial therapy of pneumonia in patients at home and as nosocomial infections. The Netherlands Antibiotic Policy Foundation]. Ned Tijdschr Geneeskd (1998) 1.98
[Belt and suspenders. Medical jargon in The Netherlands and Flanders]. Ned Tijdschr Geneeskd (1994) 1.97
Measurement of immunoreactive interleukin-1 beta from human mononuclear cells: optimization of recovery, intrasubject consistency, and comparison with interleukin-1 alpha and tumor necrosis factor. Clin Immunol Immunopathol (1988) 1.93
Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase. Blood (2001) 1.88
Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections. J Infect Dis (1995) 1.88
Tumour-targeted nanomedicines: principles and practice. Br J Cancer (2008) 1.81
Hyperimmunoglobulinaemia D and periodic fever: a new syndrome. Lancet (1984) 1.79
Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy. Arthritis Rheum (1993) 1.79
Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet (1996) 1.78
Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group. Medicine (Baltimore) (1994) 1.78
Liposomal and lipid formulations of amphotericin B. Clinical pharmacokinetics. Clin Pharmacokinet (1992) 1.74
Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome. J Clin Endocrinol Metab (1995) 1.74
Identifying physical activity patterns in chronic fatigue syndrome using actigraphic assessment. J Psychosom Res (2000) 1.72
Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities. J Infect Dis (2000) 1.70
Crosstalk between epidermal growth factor receptor- and insulin-like growth factor-1 receptor signaling: implications for cancer therapy. Curr Cancer Drug Targets (2009) 1.70
C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. Comparison with secretion of interleukin 1 beta and interleukin 1 alpha. J Exp Med (1988) 1.67
Rapid diagnosis of acute meningococcal infections by needle aspiration or biopsy of skin lesions. BMJ (1993) 1.65
Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans. J Immunol (1999) 1.64
Induction by toxic-shock-syndrome toxin-1 of a circulating tumor necrosis factor-like substance in rabbits and of immunoreactive tumor necrosis factor and interleukin-1 from human mononuclear cells. J Infect Dis (1988) 1.63
Chronic fatigue syndrome: a clinical and laboratory study with a well matched control group. J Intern Med (1995) 1.63
Plasma and whole blood exchange in meningococcal sepsis. Clin Infect Dis (1992) 1.62
Liposomes to target the lymphatics by subcutaneous administration. Adv Drug Deliv Rev (2001) 1.62
Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy. Clin Endocrinol (Oxf) (2000) 1.61
Bone mineral density in patients with recent onset rheumatoid arthritis: influence of disease activity and functional capacity. Ann Rheum Dis (1993) 1.61
Induction of circulating tumor necrosis factor (TNF alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients. J Clin Immunol (1988) 1.56
Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection. J Pharmacol Exp Ther (2001) 1.55
Sensitive determination of circulating anodic antigen in Schistosoma mansoni infected individuals by an enzyme-linked immunosorbent assay using monoclonal antibodies. Am J Trop Med Hyg (1989) 1.52
Prognosis in chronic fatigue syndrome: a prospective study on the natural course. J Neurol Neurosurg Psychiatry (1996) 1.51
Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity. Br J Cancer (2006) 1.50
Review: infectious diseases and coagulation disorders. J Infect Dis (1999) 1.50
Circulating interleukin-6 receptor in patients with sepsis syndrome. J Infect Dis (1995) 1.50
Increased circulating cytokine receptors and ex vivo interleukin-1 receptor antagonist and interleukin-1beta production but decreased tumour necrosis factor-alpha production after a 5-km run. Eur J Clin Invest (1998) 1.50
[Immunology in medical practice. XXXV. Screening of suspected immunodeficiency: diagnostic protocols for patients with opportunistic or recurrent severe infections, wasting and failure to thrive]. Ned Tijdschr Geneeskd (2000) 1.50
Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection. J Lipid Res (1999) 1.49
Selective antimicrobial modulation of human microbial flora: infection prevention in patients with decreased host defense mechanisms by selective elimination of potentially pathogenic bacteria. J Infect Dis (1981) 1.48
Fever of unknown origin (FUO). I A. prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. The Netherlands FUO Study Group. Medicine (Baltimore) (1997) 1.46
Radiolabeled interleukin-8: specific scintigraphic detection of infection within a few hours. J Nucl Med (2000) 1.46
Chlorpromazine down-regulates tumor necrosis factor-alpha and attenuates experimental multiple organ dysfunction syndrome in mice. Crit Care Med (1998) 1.44
Treatment of suspected sporadic cases of Legionnaires' disease. Lancet (1978) 1.43
[Clinical results and costs due to improved antibiotics policies]. Ned Tijdschr Geneeskd (1999) 1.43
An in vitro assay based on surface plasmon resonance to predict the in vivo circulation kinetics of liposomes. J Control Release (2011) 1.43
Long-term follow-up in toxic solitary autonomous thyroid nodules treated with radioactive iodine. J Nucl Med (1991) 1.42
Application of the ATC/DDD methodology to monitor antibiotic drug use. Eur J Clin Microbiol Infect Dis (1998) 1.42
Scintigraphic detection of bone and joint infections with indium-111-labeled nonspecific polyclonal human immunoglobulin G. J Nucl Med (1990) 1.42
Dissociation of indium from indium-111-labelled diethylene triamine penta-acetic acid conjugated non-specific polyclonal human immunoglobulin G in inflammatory foci. Eur J Nucl Med (1995) 1.41
Biodistribution and kinetics of radiolabeled proteins in rats with focal infection. J Nucl Med (1992) 1.41
[Two HIV-positive men with anorectal lymphogranuloma venereum and hepatitis C: emerging sexually transmitted diseases]. Ned Tijdschr Geneeskd (2004) 1.40
[Optimizing the antibiotics policy in the Netherlands. IV. SWAB- guidelines for antimicrobial therapy of adults with sepsis in hospitals. Foundation Antibiotics Policy Work Group]. Ned Tijdschr Geneeskd (1999) 1.39
Interleukin-1 induces tumor necrosis factor (TNF) in human peripheral blood mononuclear cells in vitro and a circulating TNF-like activity in rabbits. J Infect Dis (1990) 1.39
[Health Council Report'Preoperative evaluation: reconsideration of basic assumptions]. Ned Tijdschr Geneeskd (1997) 1.38
Retracted [Clinical reasoning and decision making in practice. A man with pneumonia and ill smelling watery sputum: the truth revealed after 80 years]. Ned Tijdschr Geneeskd (2003) 1.38
Somatic hypotheses of war syndromes. Eur J Clin Invest (2000) 1.38
[Residents not-in-training and hospital physicians: the pariahs in the hospital?]. Ned Tijdschr Geneeskd (1997) 1.38
[Somatic and psychological symptoms in soldiers after military clashes and peace-keeping missions]. Ned Tijdschr Geneeskd (1999) 1.38
[Optimizing antibiotics use policy in the Netherlands. I. The Netherlands Antibiotics Policy Foundation (SWAB)]. Ned Tijdschr Geneeskd (1998) 1.38
Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections. J Infect Dis (1994) 1.37
Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Blood (1995) 1.37
Genetic analysis as a valuable key to diagnosis and treatment of periodic Fever. Arch Intern Med (2001) 1.35
Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid compostion and lipid dose. Biochim Biophys Acta (1997) 1.35
Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250. J Clin Oncol (1997) 1.35
Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome. Eur J Hum Genet (2001) 1.34
Imaging infection/inflammation in the new millennium. Eur J Nucl Med (2001) 1.34
Synovial macrophage depletion with clodronate-containing liposomes in rheumatoid arthritis. Arthritis Rheum (2000) 1.32
Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes. J Pharmacol Exp Ther (2000) 1.32